Opto Circuits India is currently trading at Rs. 206.65, up by 1.50 points or 0.73% from its previous closing of Rs. 205.15 on the BSE.
The scrip opened at Rs. 207.25 and has touched a high and low of Rs. 209.45 and Rs. 203.25 respectively. So far 83,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 310.40 on 09-May-2011 and a 52 week low of Rs. 187.00 on 07-Oct-2011.
Last one week high and low of the scrip stood at Rs. 210.00 and Rs. 189.00 respectively. The current market cap of the company is Rs. 3,851.00 crore.
The promoters holding in the company stood at 28.05% while Institutions and Non-Institutions held 39.46% and 32.49% respectively.
Opto Circuits’ subsidiary and a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, Cardiac Science Corporation, has tied an agreement to provide 151 Powerheart AED G3 Pro units to the Hong Kong Department of Health (DH). Pacific Medical Systems, Cardiac Science's exclusive distribution partner in Hong Kong, worked closely with the DH to secure the agreement.
Opto Circuits is proud that the Hong Kong Department of Health has chosen Cardiac Science AEDs to combat sudden cardiac arrest (SCA). The units, which will be fully deployed by year’s end, will be available for medical professionals in government medical clinics throughout the region.
This alliance demonstrates the trend the company is witnessing across the globe that Governments are increasingly deploying AEDs in public buildings to save lives. The Powerheart AED G3 Pro is a fully equipped AED for medical professionals and features a color display, 3-lead ECG monitoring capability, and manual defibrillation override.
Opto Circuits India (OCI) is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Poly Medicure | 2581.85 |
| Hemant Surgical Inds | 136.50 |
| Nureca Ltd. | 273.50 |
| Prevest Denpro | 540.00 |
| Centenial Surgical | 125.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
Become a savvy and confident
stock investor.
Don't miss out! First 10 users today get it FREE
Download APP
